Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

References for PMC Articles for PubMed (Select 20161834)

1.

Update on in vitro cytotoxicity assays for drug development.

Niles AL, Moravec RA, Riss TL.

Expert Opin Drug Discov. 2008 Jun;3(6):655-69. doi: 10.1517/17460441.3.6.655.

PMID:
23506147
2.

A new fluorometric assay for cytotoxicity measurements in-vitro.

Page B, Page M, Noel C.

Int J Oncol. 1993 Sep;3(3):473-6.

PMID:
21573387
3.

Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach.

Gerets HH, Hanon E, Cornet M, Dhalluin S, Depelchin O, Canning M, Atienzar FA.

Toxicol In Vitro. 2009 Mar;23(2):319-32. doi: 10.1016/j.tiv.2008.11.012. Epub 2008 Dec 10.

PMID:
19110050
4.

A high density assay format for the detection of novel cytotoxic agents in large chemical libraries.

Shum D, Radu C, Kim E, Cajuste M, Shao Y, Seshan VE, Djaballah H.

J Enzyme Inhib Med Chem. 2008 Dec;23(6):931-45. doi: 10.1080/14756360701810082 .

5.

A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker.

Cho MH, Niles A, Huang R, Inglese J, Austin CP, Riss T, Xia M.

Toxicol In Vitro. 2008 Jun;22(4):1099-106. doi: 10.1016/j.tiv.2008.02.013. Epub 2008 Mar 4.

6.

Compound cytotoxicity profiling using quantitative high-throughput screening.

Xia M, Huang R, Witt KL, Southall N, Fostel J, Cho MH, Jadhav A, Smith CS, Inglese J, Portier CJ, Tice RR, Austin CP.

Environ Health Perspect. 2008 Mar;116(3):284-91. doi: 10.1289/ehp.10727.

7.

Multiplex caspase activity and cytotoxicity assays.

Niles AL, Moravec RA, Riss TL.

Methods Mol Biol. 2008;414:151-62. Review.

PMID:
18175818
8.

Is cell death a critical end point for anticancer therapies or is cytostasis sufficient?

Rixe O, Fojo T.

Clin Cancer Res. 2007 Dec 15;13(24):7280-7. Review.

9.

The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested.

Ulukaya E, Ozdikicioglu F, Oral AY, Demirci M.

Toxicol In Vitro. 2008 Feb;22(1):232-9. Epub 2007 Aug 23.

PMID:
17904330
10.

An improved beta-lactamase reporter assay: multiplexing with a cytotoxicity readout for enhanced accuracy of hit identification.

Hallis TM, Kopp AL, Gibson J, Lebakken CS, Hancock M, Van Den Heuvel-Kramer K, Turek-Etienne T.

J Biomol Screen. 2007 Aug;12(5):635-44. Epub 2007 May 21.

PMID:
17517902
11.

A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers.

Niles AL, Moravec RA, Eric Hesselberth P, Scurria MA, Daily WJ, Riss TL.

Anal Biochem. 2007 Jul 15;366(2):197-206. Epub 2007 Apr 12.

PMID:
17512890
12.

Optimization procedure for small interfering RNA transfection in a 384-well format.

Borawski J, Lindeman A, Buxton F, Labow M, Gaither LA.

J Biomol Screen. 2007 Jun;12(4):546-59. Epub 2007 Apr 13.

PMID:
17435168
13.

Bioluminescent assays for high-throughput screening.

Fan F, Wood KV.

Assay Drug Dev Technol. 2007 Feb;5(1):127-36. Review.

PMID:
17355205
14.

Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library.

Severson WE, Shindo N, Sosa M, Fletcher T 3rd, White EL, Ananthan S, Jonsson CB.

J Biomol Screen. 2007 Feb;12(1):33-40. Epub 2006 Dec 22.

PMID:
17200104
15.

Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors.

Kashem MA, Nelson RM, Yingling JD, Pullen SS, Prokopowicz AS 3rd, Jones JW, Wolak JP, Rogers GR, Morelock MM, Snow RJ, Homon CA, Jakes S.

J Biomol Screen. 2007 Feb;12(1):70-83. Epub 2006 Dec 8.

PMID:
17166826
16.

Comparison of in vitro assays of cellular toxicity in the human hepatic cell line HepG2.

Miret S, De Groene EM, Klaffke W.

J Biomol Screen. 2006 Mar;11(2):184-93. Epub 2005 Nov 28.

PMID:
16314402
17.

A high-throughput screen to identify inhibitors of amyloid beta-protein precursor processing.

Bakshi P, Liao YF, Gao J, Ni J, Stein R, Yeh LA, Wolfe MS.

J Biomol Screen. 2005 Feb;10(1):1-12.

PMID:
15695338
18.

Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel.

Svingen PA, Loegering D, Rodriquez J, Meng XW, Mesner PW Jr, Holbeck S, Monks A, Krajewski S, Scudiero DA, Sausville EA, Reed JC, Lazebnik YA, Kaufmann SH.

Clin Cancer Res. 2004 Oct 15;10(20):6807-20.

19.

Comparison of alamar blue and MTT assays for high through-put screening.

Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P.

Toxicol In Vitro. 2004 Oct;18(5):703-10.

PMID:
15251189
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk